HSBA

1,443.2

+0.46%↑

BARC

517

+1.33%↑

LLOY

109.45

+1.02%↑

STAN

2,051

-0.24%↓

FERG.UK

17,990

+1.35%↑

HSBA

1,443.2

+0.46%↑

BARC

517

+1.33%↑

LLOY

109.45

+1.02%↑

STAN

2,051

-0.24%↓

FERG.UK

17,990

+1.35%↑

HSBA

1,443.2

+0.46%↑

BARC

517

+1.33%↑

LLOY

109.45

+1.02%↑

STAN

2,051

-0.24%↓

FERG.UK

17,990

+1.35%↑

HSBA

1,443.2

+0.46%↑

BARC

517

+1.33%↑

LLOY

109.45

+1.02%↑

STAN

2,051

-0.24%↓

FERG.UK

17,990

+1.35%↑

HSBA

1,443.2

+0.46%↑

BARC

517

+1.33%↑

LLOY

109.45

+1.02%↑

STAN

2,051

-0.24%↓

FERG.UK

17,990

+1.35%↑

Search

ConvaTec Group PLC

Open

SectorFinanciën

209.2 2.55

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

202.6

Max

210.2

Belangrijke statistieken

By Trading Economics

Inkomsten

-34M

71M

Verkoop

85M

1.3B

K/W

Sectorgemiddelde

29.8

22.989

EPS

0.08

Dividendrendement

3.47

Winstmarge

5.575

Werknemers

10,910

EBITDA

57M

338M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+44.01% upside

Dividenden

By Acuity

Dividendrendement

Sectorgemiddelde

3.47%

4.69%

Volgende Winsten

4 aug 2026

Volgende Ex Dividend datum

20 aug 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-793M

4.1B

Vorige openingsprijs

206.65

Vorige sluitingsprijs

209.2

Nieuwssentiment

By Acuity

50%

50%

157 / 439 Rangschikking in Finance

ConvaTec Group PLC Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Over ConvaTec Group PLC

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.
help-icon Live chat